-
Posted by
Two Blokes Jun 19 -
Filed in
Stock
-
7 views
Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country's state-run health service.
